BDNF and retinal degeneration: It has been proposed that MCs are a major cellular source of BDNF [48], which has been used in clinical trials for retinal neuroprotection in various non-DR-related retinal degenerations for decades [47,49,50] and is now being considered for clinical trial for DR [51].